Latest Articles in pharmaceutical
Nirma Acquires 75% Stake In Glenmark Life For 5,651 Cr
Glenmark Pharmaceuticals on Thursday said that it has entered into a definitive agreement with Nirma to divest 75 per cent stake in its subsidiary, Glenmark Life Sciences (GLS), at a price of Rs 615 per share for an aggregate consideration of Rs 5,651.5 crores
Read More
AstraZeneca Striving To Bring Innovative Medicines To Fuel Growth In India: Sanjeev Panchal
In an exclusive interaction with BW Businessworld, Sanjeev Panchal, Country President and MD AstraZeneca India speaks on the growing pharma industry, plans for investment in India, expectations from the new drugs bill and new launches for the company
Read More
DCGI Issues Alert On Abbott's Digene Gel For Quality; Abbott Voluntarily Recalls Product In India
The Drug Controller General Of India (DCGI) Dr Rajeev Raghuvanshi has red-flagged a Digene Gel product manufactured by the pharmaceutical company Abbott India. In a letter dated 31 August 2023, the DCGI issued an alert calling the impugned product 'unsafe' and the use of which may result in adverse
Read More
Gland Pharma Gets 2 Observations On Form 483 In A Pre-market Inspection By USFDA
Gland Pharma informed that the USFDA inspected the Pashamylaram Facility at Hyderabad from 23 August 2023 to 26 August 2023
Read More
India In Final Stages To Introduce Policy On R&D In Pharma-medical Devices Sectors: Mandaviya
Acknowledging the paramount importance of research and development in healthcare advancement, Union Health Minister, Mansukh Mandaviya spoke of India's strides in fostering an innovative environment on Saturday on the sidelines of the G20 Health Minister’s Meeting in Gandhinagar
Read More
We Have Strong, Dependent Relationship With India When It Comes To Pharmaceuticals: US Health Secy
Xavier Becerra is on a visit to India to participate in the G20 Health Ministers' meeting starting in Gujarat's Gandhinagar which started today. Speaking about the session he attended during the G20 Health Ministers Meeting, he said that they talked about how they can ensure coordination and collabo
Read More
India's Zydus Lifesciences Profit More Than Doubles On US Sales Growth
The pharmaceutical company's consolidated net profit rose to 10.87 billion rupees (USD 131.3 million) in the quarter ended June 30, compared with 5.18 billion rupees a year earlier. Its U.S formulations business saw a revenue growth of 57.4 per cent to 24.54 billion rupees, while India formulations
Read More
Sanofi India Declares 12% Growth In Operating Profits
The Profit from Operations for the quarter were at INR 168 crores versus INR 150 crores in the previous year, i.e., a growth of 12% while the operating margins increased from 21.5% in Q2 2022 to 23.7% in Q2 2023
Read More
Biocon's Sales Soar By 58%, PAT Falls By 11% YoY In Q1
Bangalore-based pharmaceutical company Biocon on Thursday announced its consolidated financial results for the first quarter that ended 30 June 2023, the company registered a 58 per cent rise in its consolidated revenues from operations year on year
Read More
Even After Q2 Profit Novartis Trims Annual Sales Forecast Of Vaccines
The company's shares were up nearly 11 per cent at USD 8.32. The cash-strapped company also entered a stock deal with SK Bioscience worth about USD 85 million for part payment of a settlement amount owed to the South Korean company for manufacturing Novavax's COVID-19 vaccines
Read More